PMV Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	24.25	25.05	21.8	11.01	5.88	5.04
Research & Development	55.89	51.99	36.49	23.93	20.76	13.85
Operating Expenses	80.13	77.04	58.29	34.94	26.64	18.89
Operating Income	-80.13	-77.04	-58.29	-34.94	-26.64	-18.89
Other Expense / Income	-11.17	-3.71	-0.47	-0.51	-1.29	-1.36
Pretax Income	-68.96	-73.33	-57.82	-34.43	-25.34	-17.54
Income Tax	0	-0.01	0.02	0.01	0.01	0
Net Income	-68.96	-73.32	-57.85	-34.44	-25.35	-17.54
Shares Outstanding (Basic)	48	46	45	14	3	3
Shares Outstanding (Diluted)	48	46	45	14	3	3
Shares Change	5.31%	1.01%	214.23%	373.26%	0.76%	-
EPS (Basic)	-1.44	-1.61	-1.28	-2.40	-8.35	-5.82
EPS (Diluted)	-1.44	-1.61	-1.28	-2.40	-8.35	-5.82
Free Cash Flow	-56.62	-71.74	-47.92	-32.89	-22.17	-15.63
Free Cash Flow Per Share	-1.18	-1.57	-1.06	-2.29	-7.31	-5.19
EBITDA	-68.07	-72.68	-56.54	-34.12	-24.96	-17.2
Depreciation & Amortization	0.89	0.65	1.28	0.32	0.39	0.34
EBIT	-68.96	-73.33	-57.82	-34.43	-25.34	-17.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).